Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.7 |
mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.079 | 0.7 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.084 | 0.7 |
mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.067 | 0.7 |
mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |